The optimal dosage of pefcitinib for the treatment of active rheumatoid arthritis: A protocol for an updated network meta-analysis

BACKGROUND: Previous meta-analyses have indicated that peficitinib was the promising agent for the treatment of rheumatoid arthritis (RA). Meanwhile, a recent network meta-analysis has further investigated the comparative efficacy of different peficitinib regimes. However, pooled results from previo...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yuyi, Sun, Chunfang, Chen, Chunyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
6900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899905/
https://www.ncbi.nlm.nih.gov/pubmed/33607789
http://dx.doi.org/10.1097/MD.0000000000024586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899905/
https://www.ncbi.nlm.nih.gov/pubmed/33607789
http://dx.doi.org/10.1097/MD.0000000000024586

Ejemplares similares